Intravitreal ranibizumab (lucentis) for whole brain radiotherapy-induced maculopathy.
Department of Ophthalmology, Royal Cornwall Hospital, Treliske, Truro, UK.
S
S
Lin
Department of Ophthalmology, Royal Cornwall Hospital, Treliske, Truro, UK.
B Z
BZ
George
Department of Ophthalmology, Royal Cornwall Hospital, Treliske, Truro, UK.
N J
NJ
Wilson-Holt
D020533:Angiogenesis Inhibitors / Q000008:administration & dosage*; D061067:Antibodies, Monoclonal, Humanized / Q000008:administration & dosage*; D001932:Brain Neoplasms / Q000532:radiotherapy*; D005260:Female; D006801:Humans; D058449:Intravitreal Injections; D008268:Macular Degeneration / Q000209:etiology* / Q000532:radiotherapy*; D008875:Middle Aged; D011832:Radiation Injuries / Q000188:drug therapy* / Q000209:etiology*; D000069579:Ranibizumab
D020533:Angiogenesis Inhibitors; D061067:Antibodies, Monoclonal, Humanized; D000069579:Ranibizumab